Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance
- PMID: 3931724
Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance
Abstract
The frequency and clinical significance of acute leukemia displaying both lymphoid and myeloid characteristics was determined in 123 consecutive children using a panel of lineage-associated markers. The leukemic blasts from 18 of 95 children (19%) with the diagnosis of acute lymphoblastic leukemia (ALL) by standard diagnostic criteria expressed myeloid-associated cell surface antigens. Despite immunological evidence of lymphoid differentiation (17 CALLA + and one T cell-associated antigen +) and findings of immunoglobulin gene rearrangement, blasts from these patients reacted with one to five monoclonal antibodies identifying myeloid-associated cell surface antigens (My-1, MCS.2, Mo1, SJ-D1, or 5F1). Dual staining with microsphere-conjugated antibodies and analysis by flow cytometry confirmed that some blasts were simultaneously expressing lymphoid- and myeloid-associated antigens. Conversely, blasts from seven of 28 patients (25%) with acute nonlymphocytic leukemia (ANLL), diagnosed by otherwise standard morphological and cytochemical criteria, expressed lymphoid-associated surface antigens. Dual staining of individual blasts demonstrated simultaneous expression of myeloperoxidase (MPO) (including Auer rods) in association with either T-11, CALLA, or terminal deoxynucleotidyl transferase. Blasts from one patient with ANLL demonstrated T cell receptor gene rearrangement, while blasts from another patient demonstrated characteristics associated with T (T-11), B (CALLA and heavy-chain immunoglobulin gene rearrangement), and myeloid (MPO) lineage. There were no consistent cytogenetic abnormalities, and no patient demonstrated independent leukemic clones. Each patient with typical ALL, except for myeloid-associated antigens, achieved complete remission with conventional induction therapy for ALL. By contrast, three of the seven children with ANLL whose blasts expressed the T-11 surface antigen failed ANLL induction therapy. These three patients subsequently achieved remission with ALL therapy.
Similar articles
-
Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.Blood. 1988 Aug;72(2):579-87. Blood. 1988. PMID: 3261183
-
Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blasts.Blood. 1985 Dec;66(6):1404-8. Blood. 1985. PMID: 2415187
-
Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation.Blood. 1986 Mar;67(3):689-97. Blood. 1986. PMID: 3947743
-
Cell surface markers in leukemia: biological and clinical correlations.Crit Rev Oncol Hematol. 1985;2(3):209-60. doi: 10.1016/s1040-8428(85)80003-2. Crit Rev Oncol Hematol. 1985. PMID: 3013441 Review.
-
[Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].Folia Med Cracov. 2001;42(3):5-80. Folia Med Cracov. 2001. PMID: 12353422 Review. Polish.
Cited by
-
The molecular biology of mixed lineage leukemia.Haematologica. 2009 Jul;94(7):984-93. doi: 10.3324/haematol.2008.002436. Epub 2009 Jun 16. Haematologica. 2009. PMID: 19535349 Free PMC article. Review.
-
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing.Oncotarget. 2018 Jan 3;9(9):8441-8449. doi: 10.18632/oncotarget.23878. eCollection 2018 Feb 2. Oncotarget. 2018. PMID: 29492206 Free PMC article.
-
Cytogenetic investigations on children with acute non-lymphocytic leukemia.Blut. 1988 Jun;56(6):249-55. doi: 10.1007/BF00320283. Blut. 1988. PMID: 3382759
-
Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells.Cancer Immunol Immunother. 2010 Jan;59(1):125-35. doi: 10.1007/s00262-009-0731-6. Epub 2009 Jun 28. Cancer Immunol Immunother. 2010. PMID: 19562339 Free PMC article.
-
Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.J Hematol Oncol. 2015 Aug 21;8:100. doi: 10.1186/s13045-015-0197-2. J Hematol Oncol. 2015. PMID: 26293203 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous